CHANDA; Arani

Patent Applications and Registrations

Patent applications and USPTO patent grants for CHANDA; Arani.The latest application filed is for "salt form of a human histone methyltransferase ezh2 inhibitor".

Company Profile

7.8.12

CHANDA; Arani - Malden MA
CHANDA; Arani - Andover MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Salt Form Of A Human Histone Methyltransferase Ezh2 Inhibitor App 20210137936 - KUNTZ; Kevin Wayne ; et al.	2021-05-13
Hydrochloride Salt Form For Ezh2 Inhibition App 20210017163 - KUNTZ; Kevin Wayne ; et al.	2021-01-21
Solid State Form Of Pladienolide Pyridine Compounds And Methods Of Use App 20200361915 - Keaney; Gregg F. ; et al.	2020-11-19
Salt form of a human histone methyltransferase EZH2 inhibitor Grant 10,821,113 - Kuntz , et al. November 3, 2	2020-11-03
Crystalline Fgfr4 Inhibitor Compound And Uses Thereof App 20200317645 - MONIZ; George ; et al.	2020-10-08
Crystalline form of (2S,3S,6S,7R,10R,E)-7,10-dihydroxy-3,7-dimethyl-12-oxo-2-((R,2E,4E)-6-(pi- ridin-2-yl)hepta-2,4-dien-2-yl)oxacyclododec-4-en-6-yl-4-methylpiperazine-- 1-carboxylate and methods of use thereof Grant 10,745,387 - Keaney , et al. A	2020-08-18
Hydrochloride salt form for EZH2 inhibition Grant 10,710,987 - Kuntz , et al.	2020-07-14
Crystalline FGFR4 inhibitor compound and uses thereof Grant 10,562,888 - Moniz , et al. Feb	2020-02-18
Salt Form Of A Human Histone Methyltransferase Ezh2 Inhibitor App 20190269692 - KUNTZ; Kevin Wayne ; et al.	2019-09-05
Solid State Form Of Pladienolide Pyridine Compounds And Methods Of Use App 20190100513 - Keaney; Gregg F. ; et al.	2019-04-04
Salt form of a human histone methyltransferase EZH2 inhibitor Grant 10,245,269 - Kuntz , et al.	2019-04-02
Hydrochloride Salt Form For Ezh2 Inhibition App 20180282312 - KUNTZ; Kevin Wayne ; et al.	2018-10-04
Salt Form Of A Human Histone Methyltransferase Ezh2 Inhibitor App 20180243316 - Kuntz; Kevin Wayne ; et al.	2018-08-30
Hydrochloride salt form for EZH2 inhibition Grant 10,040,782 - Kuntz , et al. August 7, 2	2018-08-07
Crystalline Fgfr4 Inhibitor Compound And Uses Thereof App 20180093972 - MONIZ; George ; et al.	2018-04-05
Salt form of a human histone methyltransferase EZH2 inhibitor Grant 9,872,862 - Kuntz , et al. January 23, 2	2018-01-23
Salt Form Of A Human Histone Methyltransferase Ezh2 Inhibitor App 20170143729 - KUNTZ; Kevin Wayne ; et al.	2017-05-25
Hydrochloride Salt Form For Ezh2 Inhibition App 20160237068 - KUNTZ; Kevin W. ; et al.	2016-08-18
Salt form of a human histone methyltransferase EZH2 inhibitor Grant 9,394,283 - Kuntz , et al. July 19, 2	2016-07-19
Salt Form Of A Human Histone Methyltransferase Ezh2 Inhibitor App 20150065503 - Kuntz; Kevin Wayne ; et al.	2015-03-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.